Source of new products for the pharmaceutical industry

ABOUT DEVONIAN

Message from the president

“At Devonian Health Group Inc., our mission is to drive scientific advancement through pioneering innovation. We develop prescription therapeutic solutions grounded in rigorous science to address unmet medical needs and deliver sustainable value for all stakeholders. Our foundation rests on integrity, performance, and collaboration—values that shape how we operate and the partnerships we build. As we continue to expand our pipeline and global presence, our focus remains clear: to deliver meaningful innovations that enhance patient outcomes, strengthen our competitive position, and foster long-term growth for our investors and partners.’’

— Dr. André P. Boulet, PhD, Chairman & CEO

A clinical stage
pharmaceutical company

Focused on inflammatory diseases

Targeted therapies

Devonian Health Group Inc. develops prescription drugs that target multiple cellular pathways and regulate genes linked to fibroinflammatory autoimmune diseases, with a focus on gastrointestinal, dermatological, and hepatologic conditions.

Technology

Based on a broad-based platform originating from over 20 years of research.

Products

Novel therapeutics for fribroinflammatory diseases/autoimmune diseases.

Pipeline

Advanced stage products.

Investors

Focused on generating shareholder value.